Seven year Aspirin for cancer trial

NewsGuard 100/100 Score

A large clinical trial looking at the cancer preventive actions of aspirin is underway. The seven year study will include six regional centers from Victoria including Ballarat, Bendigo, Geelong, Warrnambool, Traralgon and Shepparton. The ASPirin for Reducing Events in the Elderly (ASPREE) study will involve about 19,000 participants from Australia and the United States.

According to one of the lead researchers Professor John McNeil, head of the Monash University School of Public Health and Preventive Medicine, there has been evidence that Aspirin can reduce cancer rates. He said, “The best evidence comes when we do a trial like this where we randomly allocate, just by the toss of a coin, for people to take aspirin or not take aspirin and then work out, look and observe how many cases of cancer occurred…That's the sort of evidence that doctors believe in and will change their practice as a result of it.”

The State Government has announced a $1.9 million funding for this study. The study is mainly backed by the National Institute of Health. According to Health Minister Daniel Andrews Victoria should participate in this study. He said, “When it comes to cancer, cancer is everybody's business…Everyday 70 Victorians are diagnosed with cancer, sadly 10,000 Victorians lose their life to cancer each year…That's every single Victorian right across the state touched by cancer, and it's therefore important that we try to run a proper cancer service system that benefits every single Victorian.”

Dr. Ananya Mandal

Written by

Dr. Ananya Mandal

Dr. Ananya Mandal is a doctor by profession, lecturer by vocation and a medical writer by passion. She specialized in Clinical Pharmacology after her bachelor's (MBBS). For her, health communication is not just writing complicated reviews for professionals but making medical knowledge understandable and available to the general public as well.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Mandal, Ananya. (2018, August 23). Seven year Aspirin for cancer trial. News-Medical. Retrieved on April 27, 2024 from https://www.news-medical.net/news/20100826/Seven-year-Aspirin-for-cancer-trial.aspx.

  • MLA

    Mandal, Ananya. "Seven year Aspirin for cancer trial". News-Medical. 27 April 2024. <https://www.news-medical.net/news/20100826/Seven-year-Aspirin-for-cancer-trial.aspx>.

  • Chicago

    Mandal, Ananya. "Seven year Aspirin for cancer trial". News-Medical. https://www.news-medical.net/news/20100826/Seven-year-Aspirin-for-cancer-trial.aspx. (accessed April 27, 2024).

  • Harvard

    Mandal, Ananya. 2018. Seven year Aspirin for cancer trial. News-Medical, viewed 27 April 2024, https://www.news-medical.net/news/20100826/Seven-year-Aspirin-for-cancer-trial.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
First UK real-world study shows promise for sacituzumab govitecan in metastatic breast cancer